Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION, NATURE OF BUSINESS, AND RISK AND UNCERTAINTIES (Details)

v3.23.3
ORGANIZATION, NATURE OF BUSINESS, AND RISK AND UNCERTAINTIES (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2023
Sep. 30, 2023
Number of months cash and investments sufficient to fund operating and capital expenditure   12 months
Termination fee receivable   $ 9,950
Stratasys Ltd    
Payment Received For Reimbursement Of Expenses Upon Termination Of Merger Agreement $ 10,000  
Gain (Loss) On Termination Of Merger Agreement $ 0  
Termination fee receivable   $ 10,000